Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial-Reference-Cited by-同舟云学术

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

Published:2013-02-28 Issue:2 Volume:8 Page:e57222
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ji Linong,Li Hongmei,Guo Xiaohui,Li Yan,Hu Renming,Zhu Zhengying

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Metformin therapy and clinical uses;JH Scarpello;Diab Vasc Dis Res,2008

2. Standards of medical care in diabetes –2007;Association American Diabetes;Diabetes Care,2007

3. China guideline for type 2 diabetes (2010 edition). Chin J Diabetes (Suppl 2): 1–56.

4. Standards of Medical Care in Diabetes - 2012;Association American Diabetes;Diabetes Care,2012

5. Asian-Pacific Type 2 Diabetes Policy Group (2005) Type 2 diabetes: practical targets and treatments. 4th edition ed. Available: http://www.idf.org/webdata/docs/T2D_practical_tt.pdf. Accessed 3 February 2012.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic insulin resistance affects the efficacy of metformin in patients with newly diagnosed type 2 diabetes: A Sub-Analysis of the MARCH trial;Diabetes Research and Clinical Practice;2024-08

2. Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes;Diabetes, Metabolic Syndrome and Obesity;2023-08

3. The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan;Endocrine Journal;2023

4. Expert consensus on personalized initiation of glucose‐lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease;Journal of Evidence-Based Medicine;2022-06

5. Functional annotation and enrichment analysis of differentially expressed serum proteins in patients with type 2 diabetes after dapagliflozin;World Journal of Diabetes;2022-03-15